chr1-44831039-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_003738.5(PTCH2):c.622C>T(p.Arg208Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,610,746 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R208H) has been classified as Uncertain significance.
Frequency
Consequence
NM_003738.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTCH2 | NM_003738.5 | c.622C>T | p.Arg208Cys | missense_variant | 6/22 | ENST00000372192.4 | NP_003729.3 | |
PTCH2 | NM_001166292.2 | c.622C>T | p.Arg208Cys | missense_variant | 6/23 | NP_001159764.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCH2 | ENST00000372192.4 | c.622C>T | p.Arg208Cys | missense_variant | 6/22 | 1 | NM_003738.5 | ENSP00000361266.3 | ||
PTCH2 | ENST00000447098.6 | c.622C>T | p.Arg208Cys | missense_variant | 6/23 | 1 | ENSP00000389703.2 |
Frequencies
GnomAD3 genomes AF: 0.000946 AC: 144AN: 152204Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000239 AC: 59AN: 246842Hom.: 1 AF XY: 0.000209 AC XY: 28AN XY: 134222
GnomAD4 exome AF: 0.0000933 AC: 136AN: 1458424Hom.: 1 Cov.: 31 AF XY: 0.0000827 AC XY: 60AN XY: 725386
GnomAD4 genome AF: 0.000939 AC: 143AN: 152322Hom.: 0 Cov.: 31 AF XY: 0.000846 AC XY: 63AN XY: 74470
ClinVar
Submissions by phenotype
Gorlin syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | - - |
PTCH2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 12, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at